|Videos|April 22, 2022
Q&A: Oligonucleotide Synthesis in Process Development and Scale-Up
Author(s)Cytiva
Give a quick overview of the oligonucleotide market, what is happening. Cover the typical challenges with oligonucleotide synthesis in the process development phase and solutions for those. Key considerations when scaling up oligonucleotide synthesis
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Programmable Biology Could Reshape Biologic Drug Development
2
Ask the Expert: Audits, Inspections, and CDMOs
3
Launch in Lockstep: Biopharma Readiness for the CNPV’s Accelerated Clock
4
GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment
5
